Dai-ichi Life Insurance Company’s TransUnion TRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Hold
6,563
0.01% 437
2026
Q1
$454K Hold
6,563
0.01% 437
2025
Q4
$563K Hold
6,563
0.01% 454
2025
Q3
$550K Hold
6,563
0.01% 434
2025
Q2
$578K Hold
6,563
0.02% 433
2025
Q1
$545K Hold
6,563
0.02% 442
2024
Q4
$608K Hold
6,563
0.02% 442
2024
Q3
$687K Buy
+6,563
New +$592K 0.02% 440
2022
Q4
Sell
-12,115
Closed -$721K 503
2022
Q3
$721K Hold
12,115
0.02% 414
2022
Q2
$969K Buy
12,115
+10,000
+473% +$861K 0.02% 389
2022
Q1
$219K Hold
2,115
﹤0.01% 507
2021
Q4
$251K Hold
2,115
﹤0.01% 503
2021
Q3
$238K Hold
2,115
﹤0.01% 523
2021
Q2
$232K Buy
+2,115
New +$221K ﹤0.01% 540
2021
Q1
Sell
-2,115
Closed -$210K 552
2020
Q4
$210K Buy
+2,115
New +$194K ﹤0.01% 507
2020
Q1
Sell
-2,741
Closed -$235K 531
2019
Q4
$235K Buy
+2,741
New +$228K 0.01% 514

Other funds holding TRU

Dai-ichi Life Insurance Company's TRU Position: Q2 2026 in Review

Dai-ichi Life Insurance Company held its TransUnion (TRU) position steady in Q2 2026 at 6,563 shares worth $473K. The position accounts for 0.01% of the portfolio, ranked #437.

Dai-ichi Life Insurance Company first reported a position in TRU in Q4 2019 and has held it in 16 quarters since. The position peaked at $969K in Q2 2022. 520 funds tracked by Wall St. Rank hold TRU as of Q2 2026.

  • Dai-ichi Life Insurance Company held 6,563 shares of TransUnion worth $473K as of Q2 2026.
  • Dai-ichi Life Insurance Company left its TransUnion share count unchanged in Q2 2026.
  • TransUnion made up 0.01% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #437 holding.
  • Dai-ichi Life Insurance Company first reported a position in TransUnion in Q4 2019 and has held it in 16 quarters since.
  • Dai-ichi Life Insurance Company's TransUnion position peaked at $969K in Q2 2022.
  • 520 funds tracked by Wall St. Rank held TransUnion as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.